Marianne Ellen Pavel



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN): PRRT in the Treatment of Neuroendocrine Tumor (NET) Patients (2021) Dureja S, Kolarova T, Mcdonnell M, Van Genechten D, Bouvier C, Gellerman E, O'Toole D, et al. Conference contribution Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability (2021) Dromain C, Sundin A, Najran P, Vidal Trueba H, Dioguardi Burgio M, Crona J, Opalinska M, et al. Journal article Targeted inhibition of the WEE1 kinase as a novel therapeutic strategy in neuroendocrine neoplasms (2021) Weindl L, Atreya I, Dietrich P, Neubeck S, Neurath M, Pavel ME Journal article Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study (2021) Tittel SR, Laubner K, Schmid SM, Kress S, Merger S, Karges W, Wosch FJ, et al. Journal article Target heterogeneity in oncology: The best predictor for differential response to radioligand therapy in neuroendocrine tumors and prostate cancer (2021) Puranik AD, Dromain C, Fleshner N, Sathekge M, Pavel ME, Eberhardt N, Zengerling F, et al. Journal article, Review article Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria (2021) Rinke A, Maintz C, Muller L, Weber MM, Lahner H, Pavel ME, Saeger W, et al. Journal article Treatment outcomes of advanced digestive well-differentiated grade 3 NETs (2021) de Mestier L, Lamarca A, Hernando J, Zandee W, Alonso-Gordoa T, Perrier M, Walenkamp AM, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) (2021) Apostolidis L, Dal Buono A, Merola E, Jann H, Jaeger D, Wiedenmann B, Winkler EC, Pavel ME Journal article Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment (2021) Lamarca A, Cives M, De Mestier L, Crona J, Spada F, Oberg K, Pavel ME, Alonso-Gordoa T Journal article, Review article